Oleamide MEA (85% Powder)

Analytical Code: 253045

Oleoyl‑ethanolamide (OEA) food‑grade powder; typical 125 mg BID with RCT support for appetite/weight and oxidative‑stress markers.

฿153.80
gram
Min: 0g
pieces
trending_down

Unit price will be cheaper for larger size

The price will be calculated based on the size you enter

oleoyl‑ethanolamide (OEA) — the monoethanolamide of oleic acid. That’s different from oleamide (simple amide; animal sleep lipid)


Benefit Typical study dose* Key human findings High-quality sources
Appetite & weight 250 mg/day (125 mg BID), 8 weeks ↓ hunger, body weight, BMI, waist; ↑ PPAR‑α expression vs placebo. PubMed
Oxidative stress 200–300 mg/day, 8–12 weeks ↑ TAC, SOD; ↓ MDA, ox‑LDL. Cytokines mixed across trials. Frontiers 2023
Lipids & glycemia 250–300 mg/day, 8–12 weeks Signals for ↓ triglycerides and improved fasting glucose/HOMA‑IR (pooled analyses, needs more RCTs). BMC 2024, Frontiers 2025

*Common study pattern: ≥250 mg/day for ≥8 weeks.



Mechanistic highlights

  1. PPAR‑α agonist: Gut‑derived lipid produced during fat absorption; promotes satiety and fat utilization.
  2. Vagal signaling: Intestinal OEA signals to the brain to extend inter‑meal intervals.
  3. Metabolic effects: Influences lipid handling and oxidative‑stress pathways in human studies.


Safety & practical use

  • Usual supplemental range: 125–300 mg/day (often 125 mg BID).
  • Evidence grade: Moderate and evolving; best data for appetite/weight, oxidative‑stress markers.
  • Interactions/medical advice: Advise oversight for pregnancy, chronic disease, or when on lipid/glucose‑active medication.
  • Storage: Cool, dry, sealed; protect from light/moisture. Micro limits per COA.

  • White to pale yellowish fine powder
  • Cool (15-25C)
  • 24 Months from manufacturing or testing date.
  • 125mg - 500mg
  • 125mg - 500mg
  • Powder mixing for food/beverage (oil‑phase disperse or glycol premix)
  • Heat Tolerant
  • 0.00 - 0.00
  • Soluble in Water, Dispersible in water
  • -
Test Name Specification
Appearance White to pale yellowish fine powder
Granularity 80 mesh
Content ≥85% (HPLC)
Odor & Taste Special Sour
Loss on drying ≤5.0%
Heavy metal ppm ≤10
Lead (ppm) ≤1.0
Arsenic (ppm) ≤1.50
Ash Content ≤5.0%
Total Bacteria ≤1000 cfu/g
Yeast Mold ≤100 cfu/g
Salmonella Negative
E.Coli Negative
Pesticides residues Meet the RS

Oleamide MEA (85% Powder)

Oleoyl‑ethanolamide (OEA) food‑grade powder; typical 125 mg BID with RCT support for appetite/weight and oxidative‑stress markers.

oleoyl‑ethanolamide (OEA) — the monoethanolamide of oleic acid. That’s different from oleamide (simple amide; animal sleep lipid)


Benefit Typical study dose* Key human findings High-quality sources
Appetite & weight 250 mg/day (125 mg BID), 8 weeks ↓ hunger, body weight, BMI, waist; ↑ PPAR‑α expression vs placebo. PubMed
Oxidative stress 200–300 mg/day, 8–12 weeks ↑ TAC, SOD; ↓ MDA, ox‑LDL. Cytokines mixed across trials. Frontiers 2023
Lipids & glycemia 250–300 mg/day, 8–12 weeks Signals for ↓ triglycerides and improved fasting glucose/HOMA‑IR (pooled analyses, needs more RCTs). BMC 2024, Frontiers 2025

*Common study pattern: ≥250 mg/day for ≥8 weeks.



Mechanistic highlights

  1. PPAR‑α agonist: Gut‑derived lipid produced during fat absorption; promotes satiety and fat utilization.
  2. Vagal signaling: Intestinal OEA signals to the brain to extend inter‑meal intervals.
  3. Metabolic effects: Influences lipid handling and oxidative‑stress pathways in human studies.


Safety & practical use

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...